Satish R. Desai, Omkar S. Sagade and Prashant Darakh
Page: 628-632 | Received 18 May 2024, Published online: 16 Jul 2024
Full Text Reference XML File PDF File
The American Urological Association created the international prostate symptom score (IPSS) rating system to assess the intensity of lower urinary tract symptoms (LUTS) in BPH patients. Present study was aimed to study correlation between clinical severity of symptoms by IPSS (international prostate symptom score) with ultrasound findings and prostate specific antigen. Present study was single‐center, prospective, observational study, conducted male patients with age more than 40 years, having Lower urinary tract symptoms. The study was conducted on an age group ranging from 41‐92 years with a mean age of 63.4 years. The mean IPSS score was 16.1 (range 0‐35) in this study. Serum PSA with a range of 0‐4ng/ml was having a mean value of 3.2. The mean prostate volume on ultrasound was 47.2 with the pre‐void residue of 315.7 and a post‐void residue of 144.3. On basis of IPSS score, maximum, i.e. 60 % (72 patients) were having moderate symptoms. Followed by 37 patients (30.8%) were having severe symptoms while remaining 11 patients were having mild symptoms. In our study serum PSA ranged from 0.37‐ 12.34ng/ml. 98 subjects (81.6%) had serum PSA less than 4ng/ml. While the remaining 22 subjects (18.33%) had serum PSA of more than 4ng/ml. There is a significant correlation between age and IPSS score. There is a moderate but statistically significant correlation between prostate sizes when compared to the IPSS score. There is a correlation between IPSS score and serum PSA level.
Satish R. Desai, Omkar S. Sagade and Prashant Darakh. Study of Correlation Between Clinical Severity of Symptoms by IPSS (International Prostate Symptom Score) with Ultrasound Findings and Prostate Specific Antigen.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.7.628.632
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.7.628.632